-
Published20/05/2025
-
Today12/06/2025
-
Deadline01/05/2027
Utilities
- indicates text translated automatically in your browsing language
Conclusion of non-exclusive discount agreements according to § 130a(8) SGB V (open house model) Text automatically translated in your browsing language Automatically translated
The subject of this publication is the conclusion of agreements pursuant to § 130a(8) SGB V on finished medicinal products with various active substances or combinations of active substances in the context of a so-called ‘open-house model’. Accession or conclusion of the contract may take place at any time and under the same conditions. Individual contract negotiations are not carried out. The earliest date of commencement of the contract is 01.07.2025. On this basis, the contract term is a maximum of 24 months. The contract ends on 30.06.2027 regardless of the start of the contract. Should AOK Hessen carry out a call for tenders for exclusive contracts in the form of an open procedure during the contract period for the active substances, the contracts concluded within the framework of this publication will be terminated in accordance with the contractual provisions. Text automatically translated in your browsing language Automatically translated
sen-info
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.